The nation of Zimbabwe has declined a major American health deal valued at $367m (£272m) over five years over the United States' insistence on sensitive information.
This move became public following a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government representative has since stated that the US was demanding access to health data for research and commercial purposes while was not willing to share the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further talks to find a deal acceptable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Implications
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court blocked a related deal with the US after concerns were filed about the security of citizens' health data.
Since returning to office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government deals to boost openness and accountability.
Based on statements, 16 nations in Africa have to date signed these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," he stated.
"Put simply, our country would provide the raw materials for medical research with no assurance that the end products would be accessible to our population should a new pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems already established through the global organization.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.
"This framework is intended to guarantee that when a country provides its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome further discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations should continue considering a large portion of the nation's Aids initiatives relied on foreign aid.
"If specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
The halted deal highlights the continuing challenges between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.